Beta Bionics (Nasdaq:BBNX) today provided an update on its expected commercialization timeline for its Mint patch pump system ...

New system combines Kaleido with Diabeloop’s DBLG2 algorithm and Dexcom G7, with first commercial deliveries in Germany and the Netherlands ...

Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic turning point. The company confirms its status as a global reference partner for ...

The clearance follows Glooko and mylife Diabetes Care announcing an agreement to further expand their partnership.

A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage their type 2 diabetes by recommending insulin-dose ...

A new therapy for type 1 diabetes could nix the need for insulin injections. Just a single infusion of lab-grown pancreatic cells let patients’ bodies make all the insulin they needed, scientists ...

Leo, a 22-year-old man who received a diagnosis of type 1 diabetes at 17 years of age, has struggled to meet glucose targets. As a young adult, he has many competing priorities, and diabetes is not ...